Advertisement

Topics

Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of Gastric Cancer Highlighted in a Peer-Reviewed Publication Comparing Advanced Imaging Technologies

11:59 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Meta-Analysis Shows Superiority Compared to Other Imaging Modalities Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confoca...

Other Sources for this Article

Mauna Kea Technologies
Benoit Jacheet
CFO
investors@maunakeatech.com
or
United States
The Ruth Group
Zack Kubow / Lee Roth, 646-536-7020 / 7012
zkubow@theruthgroup.com
lroth@theruthgroup.com
or
U.S. Media
The Ruth Group
Kirsten Thomas, 508-280-6592
kthomas@theruthgroup.com
or
France and Europe
NewCap - Investor Relations
Florent Alba, +33 (0)1 44 71 94 94
maunakea@newcap.fr

NEXT ARTICLE

More From BioPortfolio on "Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of Gastric Cancer Highlighted in a Peer-Reviewed Publication Comparing Advanced Imaging Technologies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...